UK experts call for new HBV (hepatitis B) testing strategy
This article was originally published in Clinica
The UK is facing a growing crisis with regard to the incidence and morbidity of hepatitis B (HBV), and urgently needs to implement a strategy to improve its diagnosis, management and research. So says the Foundation for Liver Research (FLR) in a report addressed to the UK government, citing the Department of Health's own damning statistics.
You may also be interested in...
GSK commits to investing behind OTC and oral health brands in India after offloading nutrition assets to Unilever.
The Belgian biotech has managed to attract considerable sums from venture capitalists over the past couple of years amid hopes that its two next-generation immunotherapies will be best-in-class agents.
Cipla is celebrating an “important milestone” for the company after the successful completion of a Phase III clinical trial comparing its proposed Advair generic with GSK’s brand in the US. Management has cautioned that approval will be a way off yet, however.